Physiomics PLC Confirmation of Twitter account (8079J)
16 Abril 2020 - 1:00AM
UK Regulatory
TIDMPYC
RNS Number : 8079J
Physiomics PLC
16 April 2020
16 April 2020
Physiomics plc
("Physiomics") or (the "Company")
Confirmation of Twitter account
Physiomics plc (AIM: PYC), the oncology consultancy using
mathematical models and its Virtual Tumour(TM) technology to
support the development of cancer treatment regimens and
personalised medicine solutions, would like to note that its only
official twitter account is @Physiomics.
It has come to the Company's attention that a twitter account
with a similar name, @Physiomics1, which was set up in February
this year, has been tweeting and retweeting content relating to the
Company. This account is not endorsed by and does not come from the
Company and we have requested that it be closed.
The Company will continue to keep shareholders update on any
material developments in the ordinary course, in accordance with
its regulatory obligations.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Strand Hanson Ltd (NOMAD)
Richard Tulloch & James Dance
+44 (0)20 7409 3494
Hybridan LLP (Broker)
Claire Louise Noyce
+44 (0)20 3764 2341
Notes to Editor
About Physiomics
Physiomics(R) is an oncology consultancy using mathematical
models and its Virtual Tumour(TM) technology to support the
development of cancer treatment regimens and personalised medicine
solutions. The predictive capability of Virtual Tumour has been
confirmed by 55 projects, involving over 25 targets and 60 drugs,
and has worked with clients such as Merck KGaA, Merck & Co,
Bayer and Lilly.
Based in Oxford UK, the Company works with clients worldwide to
support their pre-clinical and clinical oncology development
programs. Its team of scientists and computer modelling experts
provide bespoke solutions encompassing data, analytics and
insight.
Physiomics senior management has academic and commercial
expertise, including over 90 years collectively of working in
oncology and/or computational biology and over 100 publications in
peer reviewed journals.
For more information please visit:
www.physiomics-plc.com
www.twitter.com/Physiomics
www.linkedin.com/company/physiomics-plc/
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFELLFBZLBBBB
(END) Dow Jones Newswires
April 16, 2020 02:00 ET (06:00 GMT)
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024